Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Varying conjunctival immune response adaptations of house finch populations to a rapidly evolving bacterial pathogen

N. Kuttiyarthu Veetil, AE. Henschen, DM. Hawley, B. Melepat, RA. Dalloul, V. Beneš, JS. Adelman, M. Vinkler

. 2024 ; 15 (-) : 1250818. [pub] 20240202

Language English Country Switzerland

Document type Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't

Pathogen adaptations during host-pathogen co-evolution can cause the host balance between immunity and immunopathology to rapidly shift. However, little is known in natural disease systems about the immunological pathways optimised through the trade-off between immunity and self-damage. The evolutionary interaction between the conjunctival bacterial infection Mycoplasma gallisepticum (MG) and its avian host, the house finch (Haemorhous mexicanus), can provide insights into such adaptations in immune regulation. Here we use experimental infections to reveal immune variation in conjunctival tissue for house finches captured from four distinct populations differing in the length of their co-evolutionary histories with MG and their disease tolerance (defined as disease severity per pathogen load) in controlled infection studies. To differentiate contributions of host versus pathogen evolution, we compared house finch responses to one of two MG isolates: the original VA1994 isolate and a more evolutionarily derived one, VA2013. To identify differential gene expression involved in initiation of the immune response to MG, we performed 3'-end transcriptomic sequencing (QuantSeq) of samples from the infection site, conjunctiva, collected 3-days post-infection. In response to MG, we observed an increase in general pro-inflammatory signalling, as well as T-cell activation and IL17 pathway differentiation, associated with a decrease in the IL12/IL23 pathway signalling. The immune response was stronger in response to the evolutionarily derived MG isolate compared to the original one, consistent with known increases in MG virulence over time. The host populations differed namely in pre-activation immune gene expression, suggesting population-specific adaptations. Compared to other populations, finches from Virginia, which have the longest co-evolutionary history with MG, showed significantly higher expression of anti-inflammatory genes and Th1 mediators. This may explain the evolution of disease tolerance to MG infection in VA birds. We also show a potential modulating role of BCL10, a positive B- and T-cell regulator activating the NFKB signalling. Our results illuminate potential mechanisms of house finch adaptation to MG-induced immunopathology, contributing to understanding of the host evolutionary responses to pathogen-driven shifts in immunity-immunopathology trade-offs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007211
003      
CZ-PrNML
005      
20240423155808.0
007      
ta
008      
240412e20240202sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1250818 $2 doi
035    __
$a (PubMed)38370402
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kuttiyarthu Veetil, Nithya $u Department of Zoology, Charles University, Faculty of Science, Prague, Czechia
245    10
$a Varying conjunctival immune response adaptations of house finch populations to a rapidly evolving bacterial pathogen / $c N. Kuttiyarthu Veetil, AE. Henschen, DM. Hawley, B. Melepat, RA. Dalloul, V. Beneš, JS. Adelman, M. Vinkler
520    9_
$a Pathogen adaptations during host-pathogen co-evolution can cause the host balance between immunity and immunopathology to rapidly shift. However, little is known in natural disease systems about the immunological pathways optimised through the trade-off between immunity and self-damage. The evolutionary interaction between the conjunctival bacterial infection Mycoplasma gallisepticum (MG) and its avian host, the house finch (Haemorhous mexicanus), can provide insights into such adaptations in immune regulation. Here we use experimental infections to reveal immune variation in conjunctival tissue for house finches captured from four distinct populations differing in the length of their co-evolutionary histories with MG and their disease tolerance (defined as disease severity per pathogen load) in controlled infection studies. To differentiate contributions of host versus pathogen evolution, we compared house finch responses to one of two MG isolates: the original VA1994 isolate and a more evolutionarily derived one, VA2013. To identify differential gene expression involved in initiation of the immune response to MG, we performed 3'-end transcriptomic sequencing (QuantSeq) of samples from the infection site, conjunctiva, collected 3-days post-infection. In response to MG, we observed an increase in general pro-inflammatory signalling, as well as T-cell activation and IL17 pathway differentiation, associated with a decrease in the IL12/IL23 pathway signalling. The immune response was stronger in response to the evolutionarily derived MG isolate compared to the original one, consistent with known increases in MG virulence over time. The host populations differed namely in pre-activation immune gene expression, suggesting population-specific adaptations. Compared to other populations, finches from Virginia, which have the longest co-evolutionary history with MG, showed significantly higher expression of anti-inflammatory genes and Th1 mediators. This may explain the evolution of disease tolerance to MG infection in VA birds. We also show a potential modulating role of BCL10, a positive B- and T-cell regulator activating the NFKB signalling. Our results illuminate potential mechanisms of house finch adaptation to MG-induced immunopathology, contributing to understanding of the host evolutionary responses to pathogen-driven shifts in immunity-immunopathology trade-offs.
650    _2
$a zvířata $7 D000818
650    12
$a pěnkavovití $7 D046369
650    _2
$a konjunktiva $7 D003228
650    12
$a mykoplazmové infekce $x veterinární $x mikrobiologie $7 D009175
650    _2
$a imunita $7 D007109
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Henschen, Amberleigh E $u Department of Biological Sciences, The University of Memphis, Memphis, TN, United States
700    1_
$a Hawley, Dana M $u Department of Biological Sciences, Virginia Tech, Blacksburg, VA, United States
700    1_
$a Melepat, Balraj $u Department of Zoology, Charles University, Faculty of Science, Prague, Czechia
700    1_
$a Dalloul, Rami A $u Department of Poultry Science, The University of Georgia, Athens, GA, United States
700    1_
$a Beneš, Vladimír $u European Molecular Biology Laboratory (EMBL), Genomics Core Facility, Heidelberg, Germany
700    1_
$a Adelman, James S $u Department of Biological Sciences, The University of Memphis, Memphis, TN, United States
700    1_
$a Vinkler, Michal $u Department of Zoology, Charles University, Faculty of Science, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20240202), s. 1250818
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38370402 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155805 $b ABA008
999    __
$a ok $b bmc $g 2081290 $s 1216978
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1250818 $e 20240202 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...